Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Blue Sky Diligently Developing 'One of the Most Economic and Leveraged Uranium Plays in the Industry

The Critical Investor sits down with Nikolaos Cacos, president and CEO of Blue Sky Uranium, to discuss recent developments at the company's uranium project in Argentina. Ivana deposit; Rio Negro province, Argentina After raising C$0.87 milli...

US is winning trade war with China...for now

The ongoing battle between the United States and China for economic supremacy isn’t only being fought in the gilded ballrooms of Washington, as trade negotiators from either side parry over automobile parts content, intellectual property rights, government su...

Torq Resources’ New Gold-Copper Project a Game Changer for Investors

Torq Resources ’ latest procurement in Chile is a transformative move for the company, whose team has worked diligently to build a presence in a region dominated by major mining operations. The newly announced acquisition of the Santa Cecilia project has est...

Dec 13th 2019, Crypto Chartbook – Building positions, arriving at target loaded

Building positions, arriving at target loaded December markets are tricky. With the closing of the year come rollovers in futures markets, tax considerations, hedge fund portfolio allocations due to accountability and much more. Markets are a reflection of human behavior a...

April 28th 2020, Crypto Chartbook: Uncertainty – Who will win ?

Uncertainty – Who will win? Wouldn’t we all like to know? Fact is that nobody knows. The best a market player can do is an educated guess. Stack your odds diligently and never bet the farm. Let’s take a look at some major market players. Mi...

Rare Diseases Biotech Provides Opportunity

A ROTH Capital Partners report discussed why the stock price is at its current level and noted upcoming catalysts for the company. In a March 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi indicated that the recent drop in Soleno Therapeutics Inc.'s (SL...

United Natural Foods Share Rise 40% on Preliminary Q3/20 EPS Gain of 43%

Shares of United Natural Foods traded higher, setting a new 52-week high, after the company reported preliminary financial results for Q3/20, which demonstrated a 12% growth in y-o-y revenue and a 43% increase in earnings per share. Distributor and retailer of natu...

Dollar Tree Shares Climb 11% after Posting 8.2% Sales Growth in Q1/20

Dollar Tree shares traded higher after the firm reported Q1/20 financial results that included an 8.2% y-o-y increase in consolidated net sales fueled by a 15% y-o-y increase in same-store sales at its Family Dollar locations. Discount variety store operator Dolla...

June 26th 2020, Silver Chartbook – Silver let it ride

Silver let it ride Time relativity errors occur typically after long established sideways ranges. Meaning you get out too early of your trade. You waited a long time to finally be in your desired trade and even though everything goes perfect you want out really badly. The...

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study

Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. Clinical-stage biotechnology...
1 2 3 4 5 6 7 8 9 10 ...